STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] uniQure N.V. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Aberdeen Group plc and subsidiary abrdn Inc. have filed a Schedule 13G disclosing a new passive position in uniQure N.V. (QURE).

  • Shares owned: 2,750,714 ordinary shares
  • Ownership: 5.02 % of the outstanding class
  • Voting/Dispositive power: 0 sole / 2,750,714 shared
  • Event date: 30 Jun 2025   |  Filing signed: 30 Jul 2025
  • SEC classifications: Aberdeen – Parent Holding Company (HC); abrdn Inc. – Investment Adviser & Corporation (IA, CO)
  • Certification affirms the stake was acquired in the ordinary course and not intended to influence control.

The filing adds a sizeable institutional holder to uniQure’s share register, but because it is a 13G (passive) submission, it carries no stated activist intent.

Positive
  • abrdn/Aberdeen now hold 2.75 M uniQure shares, equating to a 5.02 % stake, adding a significant institutional investor to the shareholder base.
Negative
  • None.

Insights

TL;DR: abrdn’s 5.02 % passive stake boosts institutional ownership; impact modest but supportive.

This 13G shows Aberdeen/abrdn controls 2.75 M QURE shares with shared voting rights. Crossing the 5 % threshold introduces another large, professionally managed holder, potentially improving liquidity and signaling external confidence in uniQure. However, the passive designation means no governance pressure or strategic change is implied. Overall market impact should be limited to a mild sentiment uptick rather than a valuation-altering catalyst.

TL;DR: New 5 % holder is passive; no control intentions disclosed—neutral for governance dynamics.

Because the reporting persons filed on Schedule 13G, they expressly disclaim any effort to influence control, nominate directors, or engage in activism. All voting and dispositive authority is shared, suggesting the shares are held on behalf of clients rather than for proprietary purposes. Governance implications are therefore minimal: board composition, strategic direction, and takeover defenses remain unaffected. The only notable aspect is heightened disclosure transparency that may reassure existing investors.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Aberdeen Group plc
Signature:/s/ Frederic Osei
Name/Title:Frederic Osei, Major Shareholding Reporting Analyst
Date:07/30/2025
abrdn Inc.
Signature:/s/ Frederic Osei
Name/Title:Frederic Osei, Major Shareholding Reporting Analyst
Date:07/30/2025
Exhibit Information

Aberdeen Group plc abrdn Holdings Limited abrdn Inc. Aberdeen Group plc is the parent company. abrdn Holdings Limited is the intermediate holding company for abrdn Inc. abrdn Inc. beneficia ly owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.

FAQ

How many uniQure (QURE) shares does Aberdeen Group plc own?

Aberdeen Group plc, through abrdn Inc., reports beneficial ownership of 2,750,714 ordinary shares.

What percentage of uniQure’s outstanding shares is represented by the abrdn stake?

The filing states the position equals 5.02 % of the ordinary shares outstanding.

Does abrdn have sole or shared voting power over the shares?

abrdn Inc. has 0 sole and 2,750,714 shared votes and dispositive power; the same applies to Aberdeen Group plc.

Why was a Schedule 13G filed instead of a 13D?

Schedule 13G indicates a passive investment with no intent to influence control, unlike the activist-oriented 13D.

What is the event date that triggered this disclosure?

The reportable event occurred on 30 June 2025.

How is Aberdeen Group plc classified under SEC rules?

It is reported as a Parent Holding Company (HC) under Item 3(g).
Uniqure

NASDAQ:QURE

QURE Rankings

QURE Latest News

QURE Latest SEC Filings

QURE Stock Data

1.74B
58.43M
6.08%
96.92%
16.51%
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
AMSTERDAM